Dr. David Shafer, Chief Medical Technology Officer for Aquavit Pharmaceuticals, was recently quoted in a press release about a licensing agreement with a new microneedle device technology. “It is an innovative delivery system for botulinum toxins and dermal fillers. I use it with Botox, hyaluronic acid-based fillers and vitamin combinations”. 


Back to Blog
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at 212.888.7770.
Request an Appointment